{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T01:35:25Z","timestamp":1773624925371,"version":"3.50.1"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.toxrep.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T07:41:30Z","timestamp":1603438890000},"page":"1448-1458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety"],"prefix":"10.1016","volume":"7","author":[{"given":"Ronald N.","family":"Kostoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darja","family":"Kanduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-6518","authenticated-orcid":false,"given":"Alan L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-2918","authenticated-orcid":false,"given":"Michael B.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios A.","family":"Spandidos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0005","first-page":"1631","article-title":"A new threat from an old enemy: Re\u2011emergence of coronavirus (Review)","volume":"45","author":"Docea","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0010","first-page":"20","article-title":"COVID\u201119 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review)","volume":"22","author":"Goumenou","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"10223","key":"10.1016\/j.toxrep.2020.10.016_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0025","article-title":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China","author":"Mo","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.toxrep.2020.10.016_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-020-00647-z","article-title":"Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system","volume":"22","author":"Lima","year":"2020","journal-title":"Curr. Treat. Options Neurol."},{"issue":"15","key":"10.1016\/j.toxrep.2020.10.016_bib0035","first-page":"762","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious","volume":"71","author":"Qin","year":"2020","journal-title":"Diseases Soc. Am."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jinf.2020.02.018","article-title":"Characteristics of COVID-19 infection in Beijing","volume":"80","author":"Tian","year":"2020","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3892\/etm.2020.8797","article-title":"Interpretable artificial intelligence framework for COVID-19 screening on chest X-rays","volume":"20","author":"Tsiknakis","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/mmr.2020.11127","article-title":"Obesity \u2011 a risk factor for increased COVID\u201119 prevalence, severity and lethality (Review)","volume":"22","author":"Petrakis","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0060","first-page":"1","article-title":"Clinical characteristics of elderly patients with COVID-19 in Hunan Province, China: a multicenter, retrospective study","author":"Guo","year":"2020","journal-title":"Gerontology"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0065","series-title":"COVID-19: Preventing Future Pandemics. Georgia Institute of Technology","author":"Kostoff","year":"2020"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111418","article-title":"COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic\/pandemic events and prevalence","volume":"141","author":"Tsatsakis","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cger.2007.03.005","article-title":"Host resistance and immune responses in advanced age","volume":"23","author":"Castle","year":"2007","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111769","article-title":"SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19","volume":"146","author":"Tsatsakis","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3892\/ijmm.2020.4636","article-title":"A dissection of SARS\u2011CoV2 with clinical implications (Review)","volume":"46","author":"Stancioiu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0090","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.3892\/mmr.2017.7746","article-title":"Staphylococcus aureus colonisation in patients from a primary regional hospital","volume":"16","author":"Ungureanu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0095","first-page":"4499","article-title":"Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections","volume":"16","author":"Zlatian","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.toxrep.2020.10.016_bib0100","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3892\/etm.2017.4256","article-title":"Pharmacological management of non-alcoholic fatty liver disease: atorvastatin versus pentoxifylline","volume":"13","author":"Cioboat\u0103","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biom10010130","article-title":"Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited","volume":"10","author":"Salehi","year":"2020","journal-title":"Biomolecules"},{"issue":"1300","key":"10.1016\/j.toxrep.2020.10.016_bib0110","article-title":"The therapeutic potential of anthocyanins: current approaches based on their molecular mechanism of action","volume":"11","author":"Salehi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0115","first-page":"17","article-title":"Zinc and respiratory tract infections: Perspectives for COVID\u201119 (Review)","volume":"46","author":"Skalny","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3892\/ijmm.2020.4640","article-title":"[Editorial] COVID 19: post lockdown guidelines","volume":"46","author":"Kostoff","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0125","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/jcm8091295","article-title":"A mechanistic and pathophysiological approach for stroke associated with drugs of abuse","volume":"8","author":"Tsatsakis","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0130","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/ijerph17072326","article-title":"Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds","volume":"17","author":"Sharifi-Rad","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/jcm9041061","article-title":"Impact of natural compounds on neurodegenerative disorders: from preclinical to Pharmacotherapeutics","volume":"9","author":"Sharifi-Rad","year":"2020","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/ijerph14101282","article-title":"Endocrine disruptors leading to obesity and related diseases","volume":"14","author":"Petrakis","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0145","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fphys.2020.00694","article-title":"Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0150","unstructured":"Covid-19 Treatment and Vaccine Tracker. Milken Institute. https:\/\/milkeninstitute.org\/covid-19-tracker."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fpubh.2020.00281","article-title":"A perspective on emerging therapeutic interventions for COVID-19","volume":"8","author":"Torequl Islam","year":"2020","journal-title":"Front. Public Health"},{"issue":"572870","key":"10.1016\/j.toxrep.2020.10.016_bib0160","article-title":"Potential therapeutic options for COVID-19: current status, challenges, and future perspectives","volume":"11","author":"Sarkar","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0165","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/jcm9072084","article-title":"SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening","volume":"9","author":"Dehelean","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/ijmm.2020.4608","article-title":"Comprehensive analysis of drugs to treat SARS\u2011CoV\u20112 infection: Mechanistic insights into current COVID\u201119 therapies (Review)","volume":"46","author":"Nitulescu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0175","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.5530\/jscires.8.2.25","article-title":"Treatment repurposing using literature-related discovery","volume":"8","author":"Kostoff","year":"2019","journal-title":"J. Scientometr. Res."},{"issue":"33","key":"10.1016\/j.toxrep.2020.10.016_bib0180","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.3748\/wjg.v26.i33.4889","article-title":"Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation","volume":"26","author":"Kostoff","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111687","article-title":"The under-reported role of toxic substance exposures in the COVID-19 pandemic","volume":"145","author":"Kostoff","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/medicina56090433","article-title":"Probiotics: Versatile Bioactive Components in Promoting Human Health","volume":"56","author":"Sharifi-Rad","year":"2020","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0195","first-page":"218","article-title":"Association of nutraceutical supplements with longer telomere length","volume":"44","author":"Tsoukalas","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0200","first-page":"3701","article-title":"Discovery of potent telomerase activators: unfolding new therapeutic and anti-aging perspectives","volume":"20","author":"Tsoukalas","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","article-title":"Towards effective COVID\u201119 vaccines: Updates, perspectives and challenges (Review)","volume":"46","author":"Calina","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0210","doi-asserted-by":"crossref","DOI":"10.1007\/s40199-020-00371-8","article-title":"COVID-19 vaccines: ethical framework concerning human challenge studies","author":"Calina","year":"2020","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0215","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fmicb.2019.01781","article-title":"Recent advances in the vaccine development against middle east respiratory syndrome-coronavirus","volume":"10","author":"Yong","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0220","first-page":"1","article-title":"Vaccines for SARS-CoV-2: lessons from other coronavirus strains","author":"Padron-Regalado","year":"2020","journal-title":"Infect. Dis. Ther."},{"issue":"12","key":"10.1016\/j.toxrep.2020.10.016_bib0225","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1128\/JVI.00087-13","article-title":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein","volume":"87","author":"Fett","year":"2013","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0230","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/JVI.03566-14","article-title":"Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates","volume":"89","author":"Regla-Nava","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0235","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-020-09154-4","article-title":"Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development","author":"Calina","year":"2020","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","article-title":"Osterhaus ADME. Vaccine-induced enhancement of viral infections","volume":"27","author":"Huisman","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0260","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.4161\/21645515.2014.972148","article-title":"Could vaccination with AIDSVAX immunogens have resulted in antibody-dependent enhancement of HIV infection in human subjects?","volume":"10","author":"Shmelkov","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"Pt 7","key":"10.1016\/j.toxrep.2020.10.016_bib0265","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1099\/vir.0.000118","article-title":"Involvement of CD16 in antibody-dependent enhancement of porcine reproductive and respiratory syndrome virus infection","volume":"96","author":"Gu","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0270","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","article-title":"Viral-induced enhanced disease illness","volume":"9","author":"Smatti","year":"2018","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.toxrep.2020.10.016_bib0275","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/CVI.00316-10","article-title":"How innate immune mechanisms contribute to antibody-enhanced viral infections","volume":"17","author":"Ubol","year":"2010","journal-title":"Clin. Vaccine Immunol. CVI."},{"issue":"23","key":"10.1016\/j.toxrep.2020.10.016_bib0280","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0285","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0290","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/fvl-2017-0146","article-title":"Innate immune receptors drive dengue virus immune activation and disease","volume":"13","author":"Sprokholt","year":"2017","journal-title":"Future Virol."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0295","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00430-014-0334-5","article-title":"Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice","volume":"203","author":"Costa","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.toxrep.2020.10.016_bib0305","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement","volume":"18","author":"Jaume","year":"2012","journal-title":"Hong Kong Med. J."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0310","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.vaccine.2008.11.086","article-title":"Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS","volume":"27","author":"Klonjkowski","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jtbi.2013.04.036","article-title":"Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates","volume":"332","author":"Mier-y-Teran-Romero","year":"2013","journal-title":"J. Theor. Biol."},{"issue":"4\u20135","key":"10.1016\/j.toxrep.2020.10.016_bib0320","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.micinf.2020.04.005","article-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement","volume":"22","author":"Hotez","year":"2020","journal-title":"Microbes Infect."},{"issue":"8","key":"10.1016\/j.toxrep.2020.10.016_bib0325","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1128\/JVI.06791-11","article-title":"Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge","volume":"86","author":"Clay","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0330","first-page":"826","article-title":"Eliminating vaccine cross-reactivity","volume":"18","author":"Crunkhorn","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.toxrep.2020.10.016_bib0340","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/cti.2016.72","article-title":"Dengue virus antibodies enhance Zika virus infection","volume":"5","author":"Paul","year":"2016","journal-title":"Clin. Transl. Immunology"},{"issue":"5","key":"10.1016\/j.toxrep.2020.10.016_bib0345","first-page":"781","article-title":"Dengue virus-specific antibodies enhance brazilian zika virus infection","volume":"215","author":"Castanha","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0350","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.vaccine.2019.10.005","article-title":"Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season","volume":"38","author":"Wolff","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.toxrep.2020.10.016_bib0355","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000258","article-title":"Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada","volume":"7","author":"Skowronski","year":"2010","journal-title":"PLoS Med."},{"issue":"15","key":"10.1016\/j.toxrep.2020.10.016_bib0365","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.vaccine.2018.02.105","article-title":"Assessment of temporally-related acute respiratory illness following influenza vaccination","volume":"36","author":"Rikin","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/irv.12348","article-title":"Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections","volume":"10","author":"van Asten","year":"2016","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0375","series-title":"Association between Influenza Vaccination Rates and SARS-CoV-2 Outbreak Infection Rates in OECD Countries","author":"Lisewski","year":"2020"},{"issue":"46","key":"10.1016\/j.toxrep.2020.10.016_bib0380","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900585","article-title":"Paradoxical clade- and age-specific vaccine effectiveness during the 2018\/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)","volume":"24","author":"Skowronski","year":"2019","journal-title":"Euro Surveill."},{"issue":"48","key":"10.1016\/j.toxrep.2020.10.016_bib0385","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.48.1900720","article-title":"Influenza imprinting in childhood and the influence on vaccine response later in life","volume":"24","author":"Kelvin","year":"2019","journal-title":"Euro Surveill."},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0390","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0395","article-title":"Infection history determines susceptibility to unrelated diseases. BioEssays: news and reviews in molecular","volume":"41","author":"Rakebrandt","year":"2019","journal-title":"Cellular Dev. Biol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0400","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3389\/fimmu.2019.01589","article-title":"Route of infection strongly impacts the host-pathogen relationship","volume":"10","author":"Demars","year":"2019","journal-title":"Front. Immunol."},{"issue":"9\u201310","key":"10.1016\/j.toxrep.2020.10.016_bib0405","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.micinf.2017.12.006","article-title":"Alternative strategies for vaccination to brucellosis","volume":"20","author":"Pascual","year":"2018","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.toxrep.2020.10.016_bib0410","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-Dependent mechanism","volume":"213","author":"Aguilo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111346","article-title":"Setting safer exposure limits for toxic substance combinations","volume":"140","author":"Kostoff","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0420","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.toxrep.2018.10.010","article-title":"The role of toxic stimuli combinations in determining safe exposure limits","volume":"5","author":"Kostoff","year":"2018","journal-title":"Toxicol. Rep."},{"issue":"24","key":"10.1016\/j.toxrep.2020.10.016_bib0425","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0430","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jix074","article-title":"Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015","volume":"215","author":"Skowronski","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1334554","article-title":"Repeated annual influenza vaccination and vaccine effectiveness: review of evidence","volume":"16","author":"Belongia","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0440","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13167-017-0101-y","article-title":"Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?","volume":"8","author":"Vadala","year":"2017","journal-title":"EPMA J."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0445","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110700","article-title":"Phthalate exposure alters gut microbiota composition and IgM vaccine response in human newborns","volume":"132","author":"Yang","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2019.05.001","article-title":"How the gut microbiome regulates host immune responses to viral vaccines","volume":"37","author":"Vlasova","year":"2019","journal-title":"Curr. Opin. Virol."},{"issue":"42","key":"10.1016\/j.toxrep.2020.10.016_bib0470","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1016\/j.vaccine.2018.09.008","article-title":"Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model","volume":"36","author":"Miyazaki","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.toxrep.2020.10.016_bib0475","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1042\/CS20171106","article-title":"Role of nutrition, infection, and the microbiota in the efficacy of oral vaccines","volume":"132","author":"Bhattacharjee","year":"2018","journal-title":"Clin. Sci. (London, England: 1979)."},{"issue":"Pt 3","key":"10.1016\/j.toxrep.2020.10.016_bib0480","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1099\/0022-1317-80-3-761","article-title":"Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection","volume":"80","author":"Karlas","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"14","key":"10.1016\/j.toxrep.2020.10.016_bib0485","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1128\/JVI.76.14.6882-6892.2002","article-title":"AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts","volume":"76","author":"Giannecchini","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0490","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-018-0051-y","article-title":"FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge","volume":"3","author":"Miller","year":"2018","journal-title":"Npj Vaccines"},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fmb.09.108","article-title":"Innate immune evasion strategies of influenza viruses","volume":"5","author":"Hale","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2014.12.014","article-title":"Regulation and evasion of antiviral immune responses by porcine reproductive and respiratory syndrome virus","volume":"202","author":"Huang","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0505","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fmicb.2017.01117","article-title":"Complement evasion strategies of viruses: an overview","volume":"8","author":"Agrawal","year":"2017","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0510","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/jcp.27155","article-title":"Modulation of the immune response by Middle East respiratory syndrome coronavirus","volume":"234","author":"Shokri","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0515","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/157016207780077057","article-title":"Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope","volume":"5","author":"Toapanta","year":"2007","journal-title":"Curr. HIV Res."},{"issue":"36","key":"10.1016\/j.toxrep.2020.10.016_bib0520","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0525","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0530","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/eji.200636711","article-title":"Combined single-clade candidate HIV-1 vaccines induce T cell responses limE.-J.tEd by multiple forms of in vivo immune interference","volume":"37","author":"Larke","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0535","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original antigenic sin: how first exposure shapes lifelong anti-influenza virus immune responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0540","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: a comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874306401509010009","article-title":"The impact of vaccination on influenza-related respiratory failure and mortality in hospitalized elderly patients over the 2013-2014 season","volume":"9","author":"Joshi","year":"2015","journal-title":"Open Respir. Med. J."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0550","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.vaccine.2015.11.077","article-title":"Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains","volume":"34","author":"Kim","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0555","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.vaccine.2016.11.024","article-title":"Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: a test-negative case-control study in Japan","volume":"35","author":"Saito","year":"2017","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0560","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/cid\/ciy327","article-title":"Imprinting of repeated influenza A\/H3 exposures on antibody quantity and antibody quality: implications for seasonal vaccine strain selection and vaccine performance","volume":"67","author":"Kosikova","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0565","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons","volume":"59","author":"McLean","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/infdis\/jiz327","article-title":"The Effect of Influenza Vaccination History on Changes in Hemagglutination Inhibition Titers After Receipt of the 2015-2016 Influenza Vaccine in Older Adults in Hong Kong","volume":"221","author":"Ng","year":"2020","journal-title":"T.W.Y.he J. Infectious Diseases"},{"issue":"5","key":"10.1016\/j.toxrep.2020.10.016_bib0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216983","article-title":"Influenza vaccination in the elderly: 25 years follow-up of a randomized controlled trial. No impact on long-term mortality","volume":"14","author":"Verhees","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0580","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cit060","article-title":"Influenza vaccine effectiveness in the community and the household","volume":"56","author":"Ohmit","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0585","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-020-0175-8","article-title":"Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations","volume":"5","author":"Palgen","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.toxrep.2020.10.016_bib0590","article-title":"Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12","volume":"18","author":"Castilla","year":"2013","journal-title":"Euro Surv."},{"issue":"6","key":"10.1016\/j.toxrep.2020.10.016_bib0595","first-page":"897","volume":"67","author":"Saito","year":"2018","journal-title":"Diseases Soc. Am."},{"issue":"7","key":"10.1016\/j.toxrep.2020.10.016_bib0600","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.vaccine.2018.01.023","article-title":"Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: a systematic review and meta-analysis","volume":"36","author":"Morimoto","year":"2018","journal-title":"Vaccine"},{"issue":"200","key":"10.1016\/j.toxrep.2020.10.016_bib0605","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"40","key":"10.1016\/j.toxrep.2020.10.016_bib0610","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1016\/j.vaccine.2014.07.059","article-title":"Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs","volume":"32","author":"Rajao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0615","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2016.01.015","article-title":"Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets","volume":"491","author":"Rajao","year":"2016","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.toxrep.2020.10.016_bib0620","first-page":"14","article-title":"Immune system activation boosts HIV replication in HIV-infected people","author":"United States. National Institutes of Health NIHNIoAaID","year":"1996","journal-title":"TB HIV"},{"issue":"8","key":"10.1016\/j.toxrep.2020.10.016_bib0625","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","article-title":"Chronic immune activation in TB\/HIV Co-infection","volume":"28","author":"Sharan","year":"2020","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0630","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0635","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpedi.162.10.943","article-title":"Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study","volume":"162","author":"Szilagyi","year":"2008","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0640","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.2500\/aap.2012.33.3513","article-title":"Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study","volume":"33","author":"Joshi","year":"2012","journal-title":"Allergy Asthma Proc."},{"issue":"2","key":"10.1016\/j.toxrep.2020.10.016_bib0645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/595861","article-title":"Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season","volume":"199","author":"Belongia","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0650","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/656586","article-title":"Seasonal influenza vaccine and increased risk of pandemic A\/H1N1\u2010related illness: first detection of the association in British Columbia, Canada","volume":"51","author":"Janjua","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"51","key":"10.1016\/j.toxrep.2020.10.016_bib0655","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1016\/j.vaccine.2012.04.086","article-title":"Annual influenza vaccination affects the development of heterosubtypic immunity","volume":"30","author":"Bodewes","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0660","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/CVI.05053-11","article-title":"Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination","volume":"18","author":"Choi","year":"2011","journal-title":"Clin. Vaccine Immunol. CVI."},{"issue":"37","key":"10.1016\/j.toxrep.2020.10.016_bib0665","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1016\/j.vaccine.2011.03.055","article-title":"Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009","volume":"29","author":"Kelly","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.toxrep.2020.10.016_bib0670","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s13312-020-1936-1","article-title":"Seasonal influenza vaccination and the heightened risk of coronavirus and other pandemic virus infections: fact or fiction?","volume":"57","author":"Vashishtha","year":"2020","journal-title":"Indian Pediatr."},{"issue":"12","key":"10.1016\/j.toxrep.2020.10.016_bib0675","first-page":"2230","article-title":"Evidence in a cluster randomized controlled trial of increased 2009 pandemic risk associated with 2008-2009 seasonal influenza vaccine receipt. Clinical infectious diseases\u202f: an official publication of the infectious","volume":"69","author":"Skowronski","year":"2019","journal-title":"Diseases Soc. Am."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0680","unstructured":"Package Inserts and Manufacturers for some US Licensed Vaccines and Immunoglobulins. Institute for Vaccine Safety. Johns Hopkins University. https:\/\/www.vaccinesafety.edu\/package_inserts.htm."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0685","first-page":"637","article-title":"Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues (Review)","volume":"52","author":"Boda","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0690","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0960327112440111","article-title":"Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010","volume":"31","author":"Goldman","year":"2012","journal-title":"Human Experimental Toxicol."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0695","unstructured":"Electronic Support for Public Health\u2013Vaccine Adverse Event Reporting System (ESP:VAERS). https:\/\/digital.ahrq.gov\/ahrq-funded-projects\/electronic-support-public-health-vaccine-adverse-event-reporting-system."},{"issue":"1","key":"10.1016\/j.toxrep.2020.10.016_bib0700","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2014.02.033","article-title":"Systemic immunotoxicity reactions induced by adjuvanted vaccines","volume":"20","author":"Batista-Duharte","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"45","key":"10.1016\/j.toxrep.2020.10.016_bib0705","first-page":"90","article-title":"Vaccines and autoimmune diseases of the adult","volume":"9","author":"Orbach","year":"2010","journal-title":"Discov. Med."},{"issue":"11","key":"10.1016\/j.toxrep.2020.10.016_bib0710","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0715","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/08916930500144484","article-title":"A case-control study of serious autoimmune adverse events following hepatitis B immunization","volume":"38","author":"Geier","year":"2005","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.toxrep.2020.10.016_bib0720","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08916930290028175","article-title":"Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM","volume":"35","author":"Classen","year":"2002","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0725","article-title":"From Anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry","volume":"9","author":"Kanduc","year":"2020","journal-title":"Antibodies Basel (Basel)"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0730","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2741\/s341","article-title":"Peptide cross-reactivity: the original sin of vaccines","volume":"4","author":"Kanduc","year":"2012","journal-title":"Front. Biosci. Schol. Ed. (Schol Ed)"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0735","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1440-1711.2000.00949.x","article-title":"Computer assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences","volume":"78","author":"Natale","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0740","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.peptides.2008.05.022","article-title":"Massive peptide sharing between viral and human proteomes","volume":"29","author":"Kanduc","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.toxrep.2020.10.016_bib0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108426","article-title":"On the molecular determinants of the SARS-CoV-2 attack","volume":"215","author":"Kanduc","year":"2020","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0750","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8","key":"10.1016\/j.toxrep.2020.10.016_bib0755","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.toxrep.2020.10.016_bib0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0765","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes. Implications for the vaccine","author":"Kanduc","year":"2020","journal-title":"Immunol. Res."},{"issue":"02","key":"10.1016\/j.toxrep.2020.10.016_bib0770","doi-asserted-by":"crossref","first-page":"064","DOI":"10.1055\/s-0040-1716334","article-title":"Medical, genomic, and evolutionary aspects of the peptide sharing between pathogens, primates, and humans","volume":"07","author":"Kanduc","year":"2020","journal-title":"Global Med. Genet"},{"issue":"28","key":"10.1016\/j.toxrep.2020.10.016_bib0775","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.2174\/138161209789105135","article-title":"Self-nonself\" peptides in the design of vaccines","volume":"15","author":"Kanduc","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.toxrep.2020.10.016_bib0780","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/self.1.3.11897","article-title":"The self\/nonself issue: a confrontation between proteomes","volume":"1","author":"Kanduc","year":"2010","journal-title":"Self Nonself"},{"issue":"10","key":"10.1016\/j.toxrep.2020.10.016_bib0785","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2174\/1871520615666150716105543","article-title":"Immunogenicity, immunopathogenicity, and immunotolerance in one graph","volume":"15","author":"Kanduc","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"issue":"11","key":"10.1016\/j.toxrep.2020.10.016_bib0790","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.autrev.2016.07.030","article-title":"From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide","volume":"15","author":"Kanduc","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0795","series-title":"Prevention and Reversal of Alzheimer\u2019s Disease: Treatment Protocol","author":"Kostoff","year":"2018"},{"issue":"9","key":"10.1016\/j.toxrep.2020.10.016_bib0800","doi-asserted-by":"crossref","first-page":"707","DOI":"10.18632\/aging.100690","article-title":"Reversal of cognitive decline: a novel therapeutic program","volume":"6","author":"Bredesen","year":"2014","journal-title":"Aging"},{"issue":"Sept 18","key":"10.1016\/j.toxrep.2020.10.016_bib0805","article-title":"[Comment] COVID-19 vaccine safety","author":"Kostoff","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.toxrep.2020.10.016_bib0810","series-title":"COVID-19 Vaccine Safety Considerations","author":"Kostoff","year":"2020"}],"updated-by":[{"DOI":"10.1016\/j.toxrep.2021.10.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750020304248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750020304248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T21:01:08Z","timestamp":1705352468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750020304248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":162,"alternative-id":["S2214750020304248"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2020.10.016","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.toxrep.2021.10.004","asserted-by":"object"}]},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}